Coalition for PBM Reform Thanks FTC For Investigating PBM Practices

Washington, D.C. (February 15, 2022) — This week, the Federal Trade Commission (FTC) will host a virtual meeting with public comment, followed by a Commission vote on whether to launch a formal investigation into the predatory practices of Pharmacy Benefit Managers (PBMs). In response to this announcement, The Coalition for PBM Reform, a collective of healthcare providers, patient advocates, and pharmacy groups released the following statement: 

“The Coalition for PBM Reform is grateful to the FTC for its interest in holding PBMs accountable for their actions—which negatively affect patients, providers, and pharmacies,” said a spokesperson for the Coalition. “The Coalition met with FTC to express our concerns with the anticompetitive practices of PBMs, and bring to the commission’s attention real-life examples of patients, pharmacists, and other healthcare providers who have been hurt by PBMs. We look forward to continuing the dialogue with FTC as they look to investigate these pharmaceutical middlemen.”

FTC is scheduled to vote on February 17, and is accepting written public comment through Tuesday, February 15.